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Abstract
Background  and  objectives:  Dural  arteriovenous  ﬁstulas  are  anomalous  shunts  between  dural
arterial and  venous  channels  whose  nidus  is  located  between  the  dural  leaﬂets.  For  those  cir-
cumstances  when  invasive  treatment  is  mandatory,  endovascular  techniques  have  grown  to
become the  mainstay  of  practice,  choice  attributable  to  their  reported  safety  and  effectiveness.
We describe  the  unique  and  rare  case  of  a  dural  arteriovenous  ﬁstula  treated  by  transarterial
embolization  and  complicated  by  an  intraventricular  hemorrhage.  We  aim  to  emphasize  some
central aspects  of  the  perioperative  management  of  these  patients  in  order  to  help  improving
the future  approach  of  similar  cases.
Case  report: A  59-year-old  woman  with  a  previously  diagnosed  Cognard  Type  IV  dural  arteriove-
nous ﬁstula  presented  for  transarterial  embolization,  performed  outside  the  operating  room,
under total  intravenous  anesthesia.  The  procedure  underwent  without  complications  and  the
intraoperative  angiography  revealed  complete  obliteration  of  the  ﬁstula.  In  the  early  postopera-
tive period,  the  patient  presented  with  clinical  signs  of  raised  intracranial  pressure  attributablentricular  hemorrhage,  which  conditioned  placement  of  a  ventricularto a  later  diagnosed  intravePlease  cite  this  article  in  press  as:  de  Carvalho  JCGR,  et  al.  Intraventricular  hemorrhage  after  dural  ﬁstula  embolization.
Rev  Bras  Anestesiol.  2014.  http://dx.doi.org/10.1016/j.bjane.2014.07.015
drain, admission  to  an  intensive  care  unit,  cerebral  vasospasm  and  a  prolonged  hospital  stay.
Throughout  the  perioperative  period,  there  were  no  changes  in  the  cerebral  brain  oximetry.
The patient  was  discharged  without  neurological  sequelae.
∗ Corresponding author.
E-mail: ecarrero@clinic.ub.es (E.J. Carrero Cardenal).
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Conclusion:  Intraventricular  hemorrhage  may  be  a  serious  complication  after  the  endovascular
treatment  of  dural  arteriovenous  ﬁstula.  A  close  postoperative  surveillance  and  monitoring
allow an  early  diagnosis  and  treatment  which  increases  the  odds  for  an  improved  outcome.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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Resumo
Justiﬁcativa  e  objetivos:  Fístulas  arteriovenosas  durais  (FAVD)  são  comunicac¸ões  anômalas
entre os  canais  venosos  e  arteriais  da  dura-máter  cujo  centro  está  localizado  entre  os  fol-
hetos da  dura-máter.  Para  as  circunstâncias  nas  quais  o  tratamento  invasivo  é  obrigatório,  as
técnicas endovasculares  se  tornaram  os  pilares  da  prática,  escolha  atribuível  a  relatos  de  sua
seguranc¸a e  eﬁcácia.  Descrevemos  o  caso  único  e  raro  de  uma  FAVD  tratada  por  embolizac¸ão
transarterial  (ETA)  e  complicada  por  uma  hemorragia  intraventricular  (HIV).  Nosso  objetivo  foi
destacar  alguns  aspectos  centrais  do  manejo  perioperatório  desses  pacientes  para  ajudar  a
melhorar  uma  futura  abordagem  de  casos  semelhantes.
Relato  de  caso: Paciente  do  sexo  feminino,  59  anos  de  idade,  com  diagnóstico  prévio  de  FAVD
tipo IV  (Cognard),  apresentou-se  para  ETA,  realizada  fora  da  sala  de  cirurgia  sob  anestesia
venosa total.  O  procedimento  transcorreu  sem  complicac¸ões,  e  a  angiograﬁa  intraoperatória
revelou obliterac¸ão  completa  da  fístula.  No  período  pós-operatório  imediato,  a  paciente
apresentou  sinais  clínicos  de  aumento  da  pressão  intracraniana  (PIC)  atribuíveis  a  uma  HIV  pos-
teriormente  diagnosticada,  o  que  condicionou  a  colocac¸ão  de  um  dreno  ventricular,  internac¸ão
em Unidade  de  Terapia  Intensiva  (UTI),  vasoespasmo  cerebral  e  internac¸ão  hospitalar  prolon-
gada. Durante  todo  o  período  perioperatório,  não  houve  alterac¸ões  na  oximetria  cerebral.  A
paciente recebeu  alta  sem  sequelas  neurológicas.
Conclusão:  HIV  pode  ser  uma  complicac¸ão  grave  após  o  tratamento  endovascular  de  FAVD.  A
observac¸ão e  monitoramento  cuidadosos  no  pós-operatório  permitem  o  diagnóstico  precoce  e
o tratamento  que  aumenta  as  chances  de  um  resultado  melhor.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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en  to  ﬁfteen  percent  of  all  intracranial  vascular  malforma-
ions  are  dural  ﬁstulas  (DVAF)  which  represent  anomalous
hunts  among  arterial  branches  and  dural  venous  sinuses,
eningeal  or  cortical  veins.1--4 Depending  on  their  pattern  of
ortical  drainage,  some  DAVF  may  present  a  high  risk  of  hem-
rrhage,  and  therefore  should  be  promptly  sealed.3 In  the
ast  20  years,  endovascular  therapies  have  become  the  cor-
erstone  of  treatment  for  DVAF.3 Nevertheless,  they  are  not
nnocuous  and  patients  should  be  closely  and  continuously
onitored  for  the  appearance  of  complications.
We  report  the  case  of  a  patient  who  developed  an  intra-
entricular  hemorrhage  (IVH)  and  acute  hydrocephalus  in
he  postoperative  period  of  a  DAVF  embolization.
ase report
−2Please  cite  this  article  in  press  as:  de  Carvalho  JCGR,  et  al.  Int
Rev  Bras  Anestesiol.  2014.  http://dx.doi.org/10.1016/j.bjane.
emale,  59  years  old,  86  kg,  BMI  32  kg  m ,  ASA  III,  with
 personal  history  of  arterial  hypertension,  hypothyroidism
nd  atrial  ﬁbrillation.  In  November  2013  she  had  been  sub-
itted  to  left  atrial  appendage  closure  after  which  she  was
B
a
b
vn  double  antiplatelet  therapy  with  clopidogrel  and  aspirin
or  three  months.
On  March  2014  she  was  proposed  for  transarterial
mbolization  (TAE)  of  a DAVF  located  at  the  torcula,  clas-
iﬁed  as  Cognard  Type  IV  (Fig.  1),  after  a  ﬁrst  endovascular
rocedure  that  did  not  achieve  complete  obliteration.
At  the  pre-anesthetic  evaluation  the  patient  did  not
resent  any  focalizing  neurological  sign.  She  was  currently
edicated  with  digoxin,  atenolol,  enalapril  and  acetylsal-
cylic  acid.  Both  the  laboratory  data  and  complementary
xams  were  normal  for  age.
On  the  morning  of  the  intervention  the  patient  presented
ith  a  Glasgow  Coma  Score  (GCS)  of  15.  After  performance
f  a  summary  neurologic  exam  that  once  again  showed  no
eﬁcits  she  was  premedicated  with  midazolam  1  mg  intra-
enous  (iv).  Monitoring  consisted  of  electrocardiogram  (DII
nd  V5),  pulse  oximetry,  end  tidal  carbon  dioxide,  invasive
lood  pressure,  central  venous  pressure,  peripheral  nerve
timulator,  urinary  output,  Bispectral  Index  (BIS)  (BISTM,
rain  Function  Monitoring  System,  Covidien,  Boulder,  USA)raventricular  hemorrhage  after  dural  ﬁstula  embolization.
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nd  Near-infrared  Spectroscopy  (NIRS)  (INVOS-4100,  Cere-
ral  Oximeter,  Covidien,  Mansﬁeld,  MA,  USA).  Basal  NIRS
alues  were  62  (right  hemisphere)  and  75  (left  hemisphere).
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Figure  1  Torcular  DAVF.  Injection  of  the  right  vertebral  artery  (A)  and  right  carotid  artery  (B)  in  a  lateral  view.  The  images  show
the arterial  supply  of  the  ﬁstula  arising  from  branches  of  the  external  carotid  artery,  occipital  and  middle  meningeal  arteries  as  well
as from  the  posterior  cerebral  and  superior  cerebellar  arteries.  The  patient  showed  venous  sinus  thrombosis  as  a  probable  cause
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pfor ﬁstula  development.  The  torcular  DAVF,  with  its  cortical  ven
After  preoxygenation,  anesthesia  was  induced  using  a
Targeted  Controlled  Infusion  of  propofol  and  remifentanil
and  iv  rocuronium  (0.6  mg  kg−1 bolus  followed  by  a  per-
fusion).  After  insertion  of  a  size  4  i-gel® laryngeal  mask
for  airway  control  the  patient  was  ventilated  in  volume-
controlled  mode  adjusted  for  normocapnia,  with  a  mixture
of  50%  oxygen  in  air  and  a  positive  end-expiratory  pressure
of  5  cmH2O.
During  anesthetic  maintenance,  perfusions  were
adjusted  for  the  goals  of  BIS  between  40--60  and  train-of
four  0/4  with  post-tetanic  count  +,  as  evaluated  by  the
peripheral  nerve  stimulator.  The  concentrations  at  the
effector  site  varied  between  1.5--2.0  g  mL−1 for  propofol
and  2.0--2.5  ng  mL−1 for  remifentanil.  Rocuronium  was
infused  at  a  0.5  mg  kg−1 h−1 rate.
The  procedure  consisted  of  complete  DAVF  TAE  with
ethylene-vinyl  alcohol,  formulated  as  Onyx®,  and  it  under-
went  without  ischemic  or  hemorrhagic  incidents  (Fig.  2).
Through  it  all  there  were  no  other  complications,  the  patient
was  hemodynamically  stable  and  NIRS  values  did  not  vary
more  than  5%  compared  to  basal.
Paracetamol  1  g  and  ondansetron  4  mg  iv  were  adminis-
tered  for  analgesia  and  postoperative  nausea  and  vomiting
prophylaxis,  respectively.  At  the  end  of  surgery  neuro-
muscular  blockade  was  reversed  with  sugammadex.  When
the  patient  was  fully  awake  a  new  neurologic  examination
was  executed  and  no  new  deﬁcits  were  noted.  She  was
then  transferred  to  the  Postanesthesia  Care  Unit  (PACU)  for
overnight  monitoring.
Shortly  after  admission  the  patient  complained  of  pain
on  the  femoral  puncture  site  and  was  medicated  with  2  mg
of  iv  methadone.  Two  and  a  half  hours  later  she  developed
a  moderate  hemicraneal  right  headache  accompanied  withPlease  cite  this  article  in  press  as:  de  Carvalho  JCGR,  et  al.  Int
Rev  Bras  Anestesiol.  2014.  http://dx.doi.org/10.1016/j.bjane.
systemic  hypertension  (maximal  systolic  arterial  pressure
of  190  mmHg),  two  vomiting  episodes  and  depressed  level
of  consciousness  (GCS  =  13,  O3V4M6).  Repeated  5  mg  iv  ura-
pidil  boluses  (30  mg  total)  were  administered  to  control  the
h
t
cdrainage  pattern,  was  graded  as  Cognard  Type  IV.
cute  hypertension.  NIRS  values  remained  at  62--64  (right)
nd  72--76  (left).
An urgent  computed  tomography  (CT)  scan  was  per-
ormed  showing  an  acute  hydrocephalus,  IVH  and  diffuse
ubarachnoid  hemorrhage  (Fig.  3A).
She  was  taken  to  the  emergency  operating  room  where  a
entricular  drainage  system  was  placed  (Fig.  3B)  and  later
as  admitted  to  the  intensive  care  unit  (ICU)  sedated,  intu-
ated  and  ventilated.  Extubation  happened  within  the  ﬁrst
4  h  postadmission  and  she  was  discharged  to  the  general
ard  on  the  3rd  day.
On  the  following  days  a  generalized  and  asymptomatic
erebral  vasospasm  was  diagnosed  by  transcranial  Doppler
TCD)  but  it  slowly  responded  to  therapy  with  the  calcium-
hannel  blocker  agent  nimodipine.  The  control  CT  scan
howed  IVH  resolution  but  due  to  persistent  dilation  of
he  ventricular  system  the  patient  was  scheduled  for  ven-
riculoperitoneal  shunt  insertion  on  the  22nd  postoperative
ay.  In  the  convalescence  period  from  this  second  surgery,
onsidering  the  patient’s  clinical  and  neurological  stabil-
ty  as  well  as  her  arrhythmia  history,  antiplatelet  therapy
ith  aspirin  was  re-started.  Since  the  recovery  underwent
ithout  further  incidents  the  patient  was  discharged  home
ith  no  neurologic  deﬁcits  one  month  after  the  endovascular
mbolization.
iscussion
AVF  may  represent  a major  source  of  neurological  mor-
idity  and  mortality  as  a  result  of  the  occurrence  of
dverse  clinical  events  like  seizures,  hemorrhage  or  steal
henomena.5 The  incidence  of  these  complications  is  evenraventricular  hemorrhage  after  dural  ﬁstula  embolization.
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igher  for  DAVF  who  have  cortical  venous  drainage,6 as  in
he  case  of  our  patient.
Over  the  past  20  years,  DAVF  surgery  has  become  indi-
ated  only  when  endovascular  therapies  fail  or  are  not
ARTICLE IN PRESS+ModelBJANE-298; No. of Pages 6
4  J.C.G.R.  de  Carvalho  et  al.
F t  car
O
p
n
a
b
i
m
r
a
t
R
r
s
t
ﬁ
D
r
p
f
s
h
b
u
t
s
c
b
i
a
F
aigure  2  Injections  of  the  right  vertebral  artery  (A)  and  righ
nyx® cast.
racticable.3 In  reality  DAVF  embolization  with  Onyx®,  a
onadhesive  embolic  agent  composed  by  ethylene-vinyl
lcohol  dissolved  in  dimethyl-sulfoxide,  has  grown  to
ecome  one  of  the  major  approaches  to  DAVF,  which  is
ntimately  linked  to  its  remarkable  cure  rates  and  low
orbidity.3,5,6 In  fact,  there  are  not  many  complications
eported  after  these  techniques.  Maimon  et  al.  describe
 morbidity  of  6%  (1/17  patients)  related  to  a  transient
rochlear  nerve  palsy  and  on  a  retrospective  studied  by
angel-Castilla  et  al.,  the  authors  describe  a  complication
ate  of  9.7%  (7  of  72  patients),  of  which  only  one  corre-
ponded  to  a  intraparenchymal  hemorrhage.5,6
After  a  systematic  review  of  the  international  litera-Please  cite  this  article  in  press  as:  de  Carvalho  JCGR,  et  al.  Int
Rev  Bras  Anestesiol.  2014.  http://dx.doi.org/10.1016/j.bjane.
ure  using  the  PubMed  database,  we  were  not  able  to
nd  any  article  describing  the  occurrence  of  an  IVH  after
AVF  embolization,  which  corroborates  the  relevance  of  this
eport.
p
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igure  3  Postprocedure  computed  tomography  scan  showing  an  i
fter drainage  (B).otid  (B)  (lateral  view),  showing  total  ﬁstula  occlusion  with  the
Individuals  medicated  with  the  antiplatelet  agent  clo-
idogrel  exhibit  a  wide  variability  in  response  that  ranges
rom  hypo-to-hyper  responsiveness.  When  individuals  are
ubmitted  to  neurointerventional  procedures,  clopidogrel
yperresponsiveness  seems  to  be  associated  with  bleeding
ut  the  deﬁnitive  clinical  implications  of  these  data  are  still
nder  evaluation.7,8 Although  it  is  not  known  for  how  long
his  ‘hyper’  response  can  last,  the  fact  that  our  patient  had
topped  the  clopidogrel  more  than  a  month  before  the  pro-
edure  leads  us  to  believe  that  this  was  not  the  main  factor
ehind  the  IVH,  even  though  it  could  have  played  a  role  in
ts  etiology.
Cerebral  hyperperfusion  syndrome  (CHS),  deﬁned  as
n  excessive  increase  in  cerebral  blood  ﬂow  (CBF)  into  araventricular  hemorrhage  after  dural  ﬁstula  embolization.
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reviously  hypoperfused  area  plus  neurological  symptoms,
s  a  potentially  life-threatening  complication.  It  is  caused
y  exhaustion  of  the  cerebral  autoregulation  mechanisms
ntraventricular  hemorrhage  and  hydrocephalus  before  (A)  and
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(Normal  Perfusion  Pressure  Breakthrough  theory,  NPPB)9
and  it  can  present  with  focal  neurologic  deﬁcits,  headache,
confusion,  seizures  or  intracerebral  hemorrhage.10 Although
it  has  been  widely  reported  after  carotid  endarterectomy
(CEA)11,12 and  stenting,13 it  seems  to  be  less  common  follow-
ing  interventions  for  arteriovenous  malformations  (AVMs).14
NIRS  is  a  non-invasive  and  objective  technology  that  con-
tinuously  monitors  regional  oxygen  saturation  (rSO2).  It  is
an  early  predictive  marker  for  critical  perfusion  changes
during  endovascular  neuroradiologic  interventions.15 Both
Pennekamp  et  al.  and  Ogasawara  et  al.  described  the
use  of  this  technology  as  a  mean  to  predict  cerebral
hyperperfusion,  deﬁned  as  a  ≥100%  increase  in  CBF  from
baseline  value  assessed  with  single-photon  emission  CT,
after  CEA.11,12 Even  though  there  are  not  clearly  deﬁned  cut-
off  rSO2 values  for  cerebral  hyperperfusion,  these  authors
showed  that  an  increase  as  small  as  three  to  ﬁve  per-
centage  points  with  respect  to  basal  values  may  detect
cerebral  hyperperfusion  post-CEA  with  a  high  sensitivity  and
speciﬁcity  (100%  and  86.4%,  respectively).11,12 Both  these
parameters  increase  to  100%  with  cut-off  points  of  10%
variation.12 Whether  the  conclusions  of  these  group  stud-
ies  can  be  extrapolated  for  neurointerventional  procedures
still  needs  to  be  established.  Despite  this  lack  of  evidence,
the  stability  of  rSO2 values  made  us  consider  phenomena
other  than  CHS  as  the  cause  behind  the  patient’s  symp-
toms.
The  urgent  CT  scan  identiﬁed  both  the  IVH  and  hydro-
cephalus  and  gave  us  a  deﬁnitive  diagnosis.  The  fact  that
the  bleeding  was  restricted  to  the  ventricular  drainage  sys-
tem  conﬁrmed  our  arguments  against  the  CHS.  Young  et  al.16
showed  that  increased  CBF  following  cerebral  AVM  resection
occurs  throughout  the  entire  brain,  not  just  in  regions  that
share  the  vascular  supply  with  the  malformation.  In  that
case,  rSO2 values  would  have  to  have  increased  and  that  did
not  happen.  NIRS  technology  does  not  reﬂect  a  global  oxy-
gen  saturation.17 If  the  probe  is  placed  in  the  forehead,  as
in  our  patient,  it  is  mainly  monitoring  both  the  frontal  and
parietal  cerebral  cortex  and  thus  the  territories  irrigated  by
the  anterior  and  middle  cerebral  arteries.  This  could  explain
why  the  rSO2 did  not  increase  after  the  IVH.  Because  the
arterial  branches  supplying  the  DAVF  arose  from  the  poste-
rior  cerebral  circulation,  we  cannot  exclude  that  the  NIRS
monitor  could  be  relatively  ‘‘blind’’  to  speciﬁc  perfusion
changes  at  these  territories.  On  the  other  hand,  the  fact
that  the  rSO2 values  did  not  decrease  also  suggests  that  the
raised  intracranial  pressure  (ICP),  manifested  as  vomiting,
headache  and  diminished  level  of  consciousness,  was  com-
pensated  by  the  systemic  arterial  hypertension  and  did  not
lead  to  a  lower  cerebral  perfusion  pressure.
The  development  of  vasospasm,  as  a  response  to  the
occurrence  of  IVH  and  SAH,  is  an  indicative  that  the  patient’s
cerebrovascular  reactivity  remained  unaltered.  This  fact
argues  against  the  main  principle  underlying  the  NPPB  the-
ory  of  the  CHS.9,18
After  reviewing  the  case  with  the  radiology  team,  it
seems  more  likely  that  the  hemorrhage  was  provoked  by  one
of  two  causes:  iatrogeny  related  to  a  microperforation  whilePlease  cite  this  article  in  press  as:  de  Carvalho  JCGR,  et  al.  Int
Rev  Bras  Anestesiol.  2014.  http://dx.doi.org/10.1016/j.bjane.
retrieving  the  microcatheter  used  for  arterial  cannulation  or
hyperpressure  inside  the  DAVF  after  occlusion  of  its  venous
drainage,  maybe  secondary  to  an  arterial  branch  that  may
have  inadvertently  persisted  open.
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As  stated  earlier,  endovascular  techniques  have  increased
n  popularity  partly  due  to  their  high  safety  proﬁle.  Never-
heless,  when  anomalous  events  occur  they  may  be  severe
nd  add  morbidity,  as  we  can  infer  from  our  patient’s
rolonged  clinical  course.  This  conﬁrms  that  in  the  early
ostoperative  period  after  AVM  embolization  individuals
ave  an  increased  risk  of  neurological  complications.
How  can  we  further  improve  the  neurologic  outcome  of
hese  patients?  In  our  opinion,  this  can  be  done  by  establish-
ng  the  highest  possible  standards  of  care.  Admission  to  a
nit  where  a  close  follow-up  can  be  carried  on  by  a  properly
rained  medical  and  nursing  staff  is  crucial.  Unlike  unevent-
ul  unruptured  aneurysm  embolization,19 complications
fter  DAVF  endovascular  treatment  may  appear  several
ours  postprocedure.  For  that  reason  and  for  assuring  bet-
er  surveillance  of  cerebral  function,  we  believe  that  these
atients  should  stay  overnight  in  high  dependency  units,
uch  as  the  PACU  in  our  hospital.
A  continuous  and  detailed  clinical  examination  may
wiftly  detect  a  new  neurologic  deﬁcit,  a  depressed  level
f  consciousness  or  a  change  in  the  GCS,  allowing  a
rompt  diagnostic  or  therapeutic  intervention  that  can  ulti-
ately  result  in  an  improved  prognosis.20 In  some  cases,
euromonitors  like  NIRS  and  TCD  are  able  to  detect  cere-
ral  disturbances  even  before  symptoms  become  evident,
dentifying  individuals  at  risk  for  ischemia21 or  cerebral
yperperfusion22 after  neurovascular  techniques.  In  our
ase,  the  neurological  symptoms  were  the  key.  NIRS  helped
s  to  guide  the  diagnosis  and  the  TCD  detected  a  late  and
symptomatic  vasospasm.
Not  least  important  is  monitoring  the  patient’s  vital  signs,
ainly  arterial  blood  pressure.  While  we  could  not  ﬁnd
ata  speciﬁcally  focusing  on  DAVF,  Basali  et  al.  showed  in
heir  retrospective  study  that  postoperative  elevated  arte-
ial  pressure  is  a  correlate  for  intracerebral  bleeding  after
raniotomy.23 On  the  other  hand,  aggressive  hypertension
reatment  decreases  the  risk  of  hyperperfusion  and  intra-
erebral  hemorrhage  following  carotid  artery  stenting.13 In
ur  opinion  this  is  also  valid  after  DAVF  embolization  and
o  hypertension  control  was  a  common  concern  to  all  the
lements  involved  in  our  case.  Nevertheless,  we  think  that
he  hypertension  that  our  patient  developed,  more  than
 contributive  factor  to  the  hemorrhage,  was  a  secondary
anifestation  of  raised  ICP.
After  IVH  it  is  common  for  patients  to  present  with  clin-
cal  ﬁndings  of  obstructive  hydrocephalus,  like  depressed
evel  of  consciousness  and  vomiting,  symptoms  that  our
atient  experienced.  Even  though  there  are  reports  of
elayed  and  transient  hydrocephalus  that  resolves  spon-
aneously,  when  the  clinical  course  is  acute,  like  in  our
ase,  cerebrospinal  ﬂuid  drainage  should  be  promptly
erformed.24
When  at  the  general  ward  of  after  hospital  discharge  it
s  important  to  keep  a  close  surveillance  of  these  individ-
als.  This  is  true  because  non-occluded  AVMs  or  ﬁstulas  with
etrograde  cortical  drainage,  like  the  one  we  here  present,
re  at  a  high  risk  for  early  rebleeding.  When  this  happens,
onsequences  are  more  devastating  than  at  a ﬁrst  episode.4raventricular  hemorrhage  after  dural  ﬁstula  embolization.
2014.07.015
In  summary,  an  IVH  may  be  a  serious  complication  after
he  endovascular  treatment  of  a  DAVF.  A  close  postoperative
urveillance  and  monitoring  allow  for  an  early  diagnosis  and
reatment  and  thus  a  better  outcome.
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